<SEC-DOCUMENT>0001193125-13-355559.txt : 20130903
<SEC-HEADER>0001193125-13-355559.hdr.sgml : 20130902
<ACCEPTANCE-DATETIME>20130903161852
ACCESSION NUMBER:		0001193125-13-355559
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20130903
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130903
DATE AS OF CHANGE:		20130903

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AtriCure, Inc.
		CENTRAL INDEX KEY:			0001323885
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				341940305
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51470
		FILM NUMBER:		131075272

	BUSINESS ADDRESS:	
		STREET 1:		6217 CENTRE PARK DRIVE
		CITY:			WEST CHESTER
		STATE:			OH
		ZIP:			45069
		BUSINESS PHONE:		513-755-4107

	MAIL ADDRESS:	
		STREET 1:		6217 CENTRE PARK DRIVE
		CITY:			WEST CHESTER
		STATE:			OH
		ZIP:			45069
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d592942d8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML><HEAD>
<TITLE>Current Report</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): September&nbsp;3, 2013 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ATRICURE, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of registrant as specified in charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>000-51470</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>34-1940305</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6217 Centre Park Drive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>West Chester, OH</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>45069</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code: (513)&nbsp;755-4100 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective September&nbsp;3, 2013, the Board of Directors (the &#147;Board&#148;) of AtriCure, Inc. (the &#147;Company&#148;) appointed Scott Drake to serve as
a Director until the next Annual Meeting of Stockholders. The Board has determined that Mr.&nbsp;Drake is an independent director in accordance with guidelines that the Company has adopted, which guidelines comply with the listing standards set
forth by The NASDAQ Stock Market. Donald C. Harrison, MD, one of the founders of AtriCure, has also informed the Board of Directors of his plans to retire at the 2013 Annual Meeting in May 2014, following an orderly transition and after almost 20
years of service with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Drake is President and Chief Executive Officer of the Spectranetics Corporation (NASDAQ: SPNC). Spectranetics
develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. Its products are sold in more than 40 countries and are used to access and treat arterial blockages in the legs
and heart and to remove pacemaker and defibrillator cardiac leads.&nbsp;Since joining Spectranetics in August 2011 as its President and Chief Executive Officer, Mr.&nbsp;Drake has led it through significant growth. Spectranetics reported $140.3
million in revenue in 2012. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to joining Spectranetics, Mr.&nbsp;Drake was Senior Vice President, Operations of DaVita, Inc. (NYSE: DVA), a leading
U.S. provider of kidney care and dialysis. At DaVita, he had responsibility for business operations that generated approximately 20% of the company&#146;s revenue, which exceeded $6 billion. Previously, Mr.&nbsp;Drake held several positions of
increasing responsibility within various healthcare business units at Covidien, Plc over a period of 17 years. From 2006 to 2009, Mr.&nbsp;Drake was Global Business Unit President, Respiratory and Monitoring Solutions, a $1.5 billion business with
8,000 employees. Under his leadership, significant operational improvements were made including revenue and profit growth, enhanced new product development pipeline, lifting of FDA consent decree and lean six sigma operational excellence
initiatives. Foundational to these accomplishments is an intense focus on new product development, organizational effectiveness and customer needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There
is no arrangement or understanding between Mr.&nbsp;Drake and any other person pursuant to which Mr.&nbsp;Drake was appointed as a Director of the Company, and there have been no transactions nor are there any proposed transactions between the
Company and Mr.&nbsp;Drake that would require disclosure pursuant to Item&nbsp;404(a) of Regulation S-K. Mr.&nbsp;Drake will receive compensation for his service as a director in accordance with the Company&#146;s compensation policies for
non-employee directors, which are described under the heading &#147;Director Compensation&#148; in the Company&#146;s proxy statement filed with the SEC on April&nbsp;12, 2013. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release announcing Mr.&nbsp;Drake&#146;s appointment is furnished as Exhibit 99.1 and incorporated by reference in this Item&nbsp;5.02.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:11.80pt; font-size:8pt; font-family:Times New Roman">No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated September 3, 2013</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3">ATRICURE, INC.</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>Dated: September&nbsp;3, 2013</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">/s/ M. Andrew Wade</P></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">M. Andrew Wade</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Vice President and Chief Financial Officer</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d592942dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g592942g99u99.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Contact: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AtriCure, Inc.
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Andy Wade </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President and Chief Financial Officer
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(513) 755-4564 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">awade@atricure.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lynn Pieper </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westwicke Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(415) 202-5678 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">lynn.pieper@westwicke.com </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AtriCure Appoints
Scott Drake to its Board of Directors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WEST CHESTER, Ohio &#150; September&nbsp;3, 2013 &#150; AtriCure, Inc. (NASDAQ: ATRC), a medical device company
and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, today announced that Scott Drake, Chief Executive Officer of the
Spectranetics Corporation, has been elected as Director. Donald C. Harrison, MD, one of the founders of AtriCure, has also informed the Board of Directors of his plans to retire at the 2013 Annual Meeting in May 2014, following an orderly transition
and after almost 20 years of service with the company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Drake is President and Chief Executive Officer of the Spectranetics Corporation (NASDAQ:
SPNC). Spectranetics develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. Its products are sold in more than 40 countries and are used to access and treat arterial
blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads.&nbsp;Since joining Spectranetics in August 2011, Mr.&nbsp;Drake has led it through significant growth. Spectranetics reported $140.3 million in revenue in
2012. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to joining Spectranetics, Mr.&nbsp;Drake was Senior Vice President, Operations of DaVita, Inc. (NYSE: DVA), a leading U.S. provider of kidney
care and dialysis. At DaVita, he had responsibility for business operations that generated approximately 20% of the company&#146;s revenue, which exceeded $6 billion. Previously, Mr.&nbsp;Drake held several positions of increasing responsibility
within various healthcare business units at Covidien, Plc over a period of 17 years. From 2006 to 2009, Mr.&nbsp;Drake was Global Business Unit President, Respiratory and Monitoring Solutions, a $1.5 billion business with 8,000 employees. Under his
leadership, significant operational improvements were made including revenue and profit growth, enhanced new product development pipeline, lifting of FDA consent decree and lean six sigma operational excellence initiatives. Foundational to these
accomplishments is an intense focus on new product development, organizational effectiveness and customer needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are thrilled to welcome Scott
to our Board of Directors, and look forward to his contribution to AtriCure. As a seasoned executive, Scott has significant leadership experience managing growing businesses, achieving sustainable revenue growth and driving operational improvements.
I believe he will bring meaningful value to AtriCure and to our Board of Directors,&#148; said Michael Carrel, President and Chief Executive Officer of AtriCure. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am pleased to be joining AtriCure&#146;s Board of Directors, and look forward to contributing to the
company&#146;s ongoing success and commercial efforts,&#148; said Mr.&nbsp;Drake. &#147;AtriCure is at an exciting stage in its development as a company, and is emerging as a true leader in the field of atrial fibrillation.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Don Harrison has also announced that, following an orderly transition and succession, he will be retiring from the Board of Directors of AtriCure at
the 2013 Annual Meeting in May 2014. Dr.&nbsp;Harrison has had an illustrious career spanning over 50 years. Prior to the founding of Charter Life Sciences, he was the senior vice president and provost for health affairs at the University of
Cincinnati Medical Center, where he was responsible for three hospitals, more than 1000 faculty and over $240 million in funded research. Previously, he was Chief of Cardiology at Stanford University and Co-Director of the Falk Cardiovascular
Research Center at Stanford University. Among his many professional honors, he has been the president of the American Heart Association and a trustee of the American College of Cardiology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Dr. Harrison was critical to the founding of AtriCure, and his extensive clinical and scientific expertise in cardiology and knowledge of atrial
fibrillation have been invaluable to AtriCure&#146;s success,&#148; said Mike Carrel, AtriCure&#146;s President and Chief Executive Officer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About
AtriCure, Inc. </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AtriCure, Inc. is a medical device company providing innovative atrial fibrillation (Afib) solutions designed to produce superior
outcomes that reduce the economic and social burden of atrial fibrillation. AtriCure&#146;s Synergy Ablation System is the first and only device approved for the treatment of Persistent and Longstanding Persistent forms of Afib in patients
undergoing certain open concomitant procedures. AtriCure&#146;s AtriClip Left Atrial Appendage (LAA) exclusion device is the most widely implanted device for LAA management worldwide.&nbsp;The company believes cardiothoracic surgeons are adopting
its ablation and LAA management devices for the treatment of Afib and reduction of Afib related complications such as stroke. Afib affects more than 5.5&nbsp;million people worldwide. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Forward-Looking Statements </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release
contains &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that address activities, events or developments that AtriCure expects, believes
or anticipates will or may occur in the future, such as earnings estimates (including projections and guidance), other predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure&#146;s products.
Forward-looking statements are based on AtriCure&#146;s experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and
uncertainties, many of which are beyond AtriCure&#146;s control. These risks and uncertainties include the rate and degree of market acceptance of AtriCure&#146;s products, AtriCure&#146;s ability to develop and market new and enhanced products, the
timing of and ability to obtain and maintain regulatory clearances and approvals for its products, the timing of and ability to obtain reimbursement of procedures utilizing AtriCure&#146;s products, competition from existing and new products and
procedures or AtriCure&#146;s ability to effectively react to other risks and uncertainties described from time to time in AtriCure&#146;s SEC filings, such as fluctuation of quarterly </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial results, reliance on third party manufacturers and suppliers, litigation or other proceedings, government regulation and stock price volatility. AtriCure does not guarantee any
forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. A
further list and description of risks, uncertainties and other matters can be found in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g592942g99u99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g592942g99u99.jpg
M_]C_X0UM17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``#J5^```G$``.I7X``"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q,SHP.3HP,R`R,CHQ.3HP,P```Z`!
M``,````!``$``*`"``0````!````V*`#``0````!````+``````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```PW`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`(0"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]57)_P",+K-V!@48>+<^
MC(RW[G65N+'MJJA]FVQA#Z_4M=37_4]1=8N#Q?\`LB_Q@6Y!A^%TEI:V1()K
M+J6#3_29=F1=_4QE+A`XC(_+`<1_[EBS$\(C'24SPC_NBV_\7G6K\NG*Z?F7
M/OR*'"ZJRYY>\U6:.9N?N>[T;FN_[>J78KRG!>[ZK?6\5/=MHQ[CCV$GG&OV
MFFQY_P"":['N?_Q#UZ=GNSF8=IZ?77;F1%++G%E>XZ;K7,:]^QGT_9]-.YB`
M$P8_+,<06\O,F!$OF@3$M;(ZWB4]9Q>C-FS+R6OL<&D176QI=OM_XUXV5,_X
MS_1K17DO3J^OO^L]M>+D,_;8?>VW)MU8Y[!LR(FM_LVMV4-]']'7_HUV^`SZ
M[8W3\ZS/NQ<K,`:[":1%<-#O6;9Z->.[W_F)9,(C52&P_%6+,9\7IEN?^:]&
MA93+[,6YF,\57N8YM5A$AKR"*WEO\AZ\WZ;]<_K#?]I;6]V7U/J!IJZ?2U@%
M=0_369-K*![=S&.K_G[?^$OL]"E;'U=_YYX_4,W&ZBY[\BS&];%;EN#Z"\/V
M/B[%:[T]K7>^FO\`[:0E@E&[,172_F3'/&=<(D;ZU\J/ZD]#^LV!U:V_J+;*
M<<U.9?ZEPM]:TECF6-`LMW;/TC_M#]C_`-)Z?^D73=;ZRSIE36L`LRK9]*L\
M`#Z5MO\`P;/_``1<S]3OK#UGK'UBM;U"Z*V8MKABUM#*V/%M%9T][['L][=]
MEKT3+_RG]8W56:UOO%&W_@JI]1G_`%S9;_VXJWQ++DQT!7N9"(1X=A;8^'X\
M<P3K[<.*4N+<TV<3IG6NLL&5E9;ZJ+-:P9&X=GUX['5UUU_N/L_2/4LGZM]2
MPV&_"RGVN9J6,+JK([^F6/V/=_(<MKK76L'H>#]KR]VPN%===8E[WGZ-=;?:
MWZ+7.]SE5^KWUJZ?U[U:Z&OHR*0'/HMB=IT%M;F.>RRO=[/Y'_;:B'P^)AQ'
MCD>N7BE?$R'G9"?".&(Z8ZC7"W>BWV9'2L6^U_J665-<YY@$F.=(5U976SD8
M/33?@6_9_0<"Y@:US7![@'Z/'M]S]_M2^KN9E9N`^W*?ZE@M>P.VAN@VQHQ.
MCE`G'";,^`2XOT9(EC)@<HH1XJX>H=5)<S]8>I]4P,\5XV3MJM8'AA8QVT[M
MCF[BW=M6GU_,S\+#^T8GIAH(;:YX)<T.(8U];9#?I._.2^\0_6Z2_4_/_P"@
MJ]B7ZO4?K?E_]"=-)<CC]3ZWF8S,+"<^W)&^S*O.T$!SW>E6Q[HJJ;L_D_\`
M%?X1:&!U')P.CWW=2]1^11<ZIM=A&]Q.WTJP_P#/:[=_._Z--AS<)=)"/#Q<
M9'HTWC?[RZ7+2CUB97P\`/K\)4[R2YC%I^LG5J?MOVT8K'2:*V"&N`^'O]/]
MU]GJ[_W%/I?4NH9MCNFY-OI9=#B[U!`+PP[+:[-GM]2I[FN]GZ.^I`<T"1Z)
MCC_FR:_6?]ZH\N0#ZXG@^<"_0__0]"^LG5#TGHF5FM/Z9K-F./&VP^E3_6_2
M/WN_D+@?JI]9\/ZO8EM1PK\J_(>'/O8(:6M&RIC=WTO\)9_QEJM_XPNMXN?G
M8_1*<AC:\>P?:[B?8RU_Z!H<[_NI59;;=^YO9^>O0<:FFC'JHH`;34QK*FC@
M-:-K`/[*L"L>("4;]PWOP^F/RM<WDRDQE7MBMN+U2^9\I^M'6<3KN77EUXMV
M*_TS1>+0-KVSNI+'-_PC=]WTOY"]!^I_53U3H./=8[=D4@X^0>3ZE7LWN_XZ
MOT[_`/KJ)]:L.G,^KV?3<\5M;4ZUMCC`:^K]-4]SOW?4K;N7#?4#ZQ8V!U%^
M'DV"O'ZB&EKG&&LO:(8UVZ&M]>MWI?\`&TTIQK+A/#&O;.@^;TK1>+..*5C*
M.W#ZDW0?_P`HN1_X8S?XKT7(_H]O]1WY%YC?F.^KOUXR,S+K):+[K=@@.?1D
M`[;:-^UEFR?\^JRI=C@?6>OJF#G=4-1P^C8]9;7D7P'6O`=Z]C`USF^A5[*F
M?3]:[U/]$AGB3P2'R\,1?BGEY`"<#\W%(UX/,?XK\>M_4,C(<)?1BULK\O5<
M[U#_`.`,7I"\W_Q796.S/RL9U@%UV/4:V'0N],V>KM_J>JQ>C665U5NMM<*Z
MZP7/>X@-:T"7.<X_1:U-YJ_=/T7<K7M#ZOG/^+[_`,5.7_Q&1_[<4K0+_L'U
MA=9;[6U9;G/)[,M)]_\`VW?O61_B_P`[$'UHL)L#?M=-[:`[3<YUM=[6?UW5
M,>]=C]8^B699&;B-#[VMVW4Z#U&CZ);/M]6N?SOYRM5?BV*<C&4!<L?#,#NV
M/A>2,8RC(U&?%&TGUJ^KYZ]T]M%5HIR*+/5H>X$L+H=6ZNW;[MEC'_2;]!4/
MJA]4,CHF1=FYUU=F3:ST:V4[BQK)]1[G/L#'/LL>UG^#_1[$+IOUFMZ>P8>;
M6ZQM7M;/LN8!_@WUW;/4VJSD?6YUWZ#IN,]][]&E\.(_JTTN?O\`[;ZTR/Q+
M'[?#Q5>\*]?%^ZR2^'S]SBX;K:=^FOWG2^LO_(F3\&?]6Q5_JE_R8_\`X]__
M`'U*SI^>_P"K5N+>?4SGM=8\3N)>7_:!7N^CN_P?L_1_N?HUD]#^L.-TVBVG
M(:Y];GFQCF1N!(`?6]CW,V_15>>01YG'DGZ(RQ5ZNDOFX2SPQF6"<(>LQR?H
M]1^\S^N'_*%/_$_]_6S]9_\`D6_^M7_Y\K7,]8R,S-R69%]1J=D,_5,>"7^F
MQWMW,`W_`*5YW?16]]8<VNSH.ZQKJ'Y#JPRJT;7R'M>X%G\EC'*.,Q+[X=N*
M.EZ?HR7R@1]U&]2UK7]*++ZIU-;TQUH'NMM>7'O[?T31_P!!5OKD]WIXE>NP
MNL<0/%K=K?\`SX]6?JE=59TLUL<"^JUX>WN-Q]1G^<UR/]8.FV9^$/0$Y%#O
M4K;QNT+7U;C^^P^W_A%+P&?)",-28#;P]4F+B$>;)EH.([_\UI8C/K0<2@XU
MF(*#6ST@0Z=FT;)]O[JCA]%ZPSK%?4<DT:N<Z[TW.U!8:O:PL_J?GJGTCZQC
MIU1P\MCG5U$A@$-LKUUJLJM-?M:M;!ZOD=7RF_8ZG4X%)W7WOB7D?0QZMN]O
MTO?<_=]#]'_A$S$<.3V[G.4XD$8R;X9Q_P"Y7Y!EAQ^F`@01QU7%&3__T?4:
M?YH?$_E*5'\S7_5'Y%\LI)(?J>[Z(_K-_P"J:E=_,V?U3^1?+"22GW_Z^?T?
M"_KN_(U=#C_T'&_JU?\`?5\OI*67\W#SDQQ_G<GE%^IK?I5_U_X.2O\`YH_+
M\J^64E$R=WZGM^B/ZS?^J:IKY5222_2GU@_F&?$I?5[^CO\`B/R+YK257_P5
M]&Q_X'_PGZJ6#9_XH6_UA^0+YS23^8VA_?BLP[S_`+A?I[_O6_\`0?\`[^K1
M_G!\#_WU?*Z2DC^E_>62Z>3]4?X0_P!7^*DOE5).6OT7]8?Z35_5_B5M8W]'
MJ_J-_(OEI)08OY[+]&;)_-8_J__9_^T5)E!H;W1O<VAO<"`S+C``.$))300E
M```````0`````````````````````#A"24T$.@``````Y0```!`````!````
M```+<')I;G1/=71P=70````%`````%!S=%-B;V]L`0````!);G1E96YU;0``
M``!);G1E`````$-L<FT````/<')I;G13:7AT965N0FET8F]O;``````+<')I
M;G1E<DYA;65415A4`````0``````#W!R:6YT4')O;V93971U<$]B:F,````,
M`%``<@!O`&\`9@`@`%,`90!T`'4`<```````"G!R;V]F4V5T=7`````!````
M`$)L=&YE;G5M````#&)U:6QT:6Y0<F]O9@````EP<F]O9D--64L`.$))300[
M``````(M````$`````$``````!)P<FEN=$]U='!U=$]P=&EO;G,````7````
M`$-P=&YB;V]L``````!#;&)R8F]O;```````4F=S36)O;VP``````$-R;D-B
M;V]L``````!#;G1#8F]O;```````3&)L<V)O;VP``````$YG='9B;V]L````
M``!%;6Q$8F]O;```````26YT<F)O;VP``````$)C:V=/8FIC`````0``````
M`%)'0D,````#`````%)D("!D;W5B0&_@````````````1W)N(&1O=6)`;^``
M``````````!";"`@9&]U8D!OX````````````$)R9%15;G1&(U)L=```````
M`````````$)L9"!5;G1&(U)L=````````````````%)S;'15;G1&(U!X;$!7
M_RL`````````"G9E8W1O<D1A=&%B;V]L`0````!09U!S96YU;0````!09U!S
M`````%!G4$,`````3&5F=%5N=$8C4FQT````````````````5&]P(%5N=$8C
M4FQT````````````````4V-L(%5N=$8C4')C0%D````````````08W)O<%=H
M96Y0<FEN=&EN9V)O;VP`````#F-R;W!296-T0F]T=&]M;&]N9P`````````,
M8W)O<%)E8W1,969T;&]N9P`````````-8W)O<%)E8W12:6=H=&QO;F<`````
M````"V-R;W!296-T5&]P;&]N9P``````.$))30/M```````0`%_\K``!``(`
M7_RL``$``CA"24T$)@``````#@`````````````_@```.$))300-```````$
M````'CA"24T$&0``````!````!XX0DE-`_,```````D```````````$`.$))
M32<0```````*``$``````````CA"24T#]0``````2``O9F8``0!L9F8`!@``
M`````0`O9F8``0"AF9H`!@```````0`R`````0!:````!@```````0`U````
M`0`M````!@```````3A"24T#^```````<```________________________
M_____P/H`````/____________________________\#Z`````#_________
M____________________`^@`````_____________________________P/H
M```X0DE-!`@``````!`````!```"0````D``````.$))300>```````$````
M`#A"24T$&@`````#10````8``````````````"P```#8````"`!I`&T`80!G
M`&4`,``P`#$````!``````````````````````````$``````````````-@`
M```L``````````````````````$`````````````````````````$`````$`
M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M```L`````%)G:'1L;VYG````V`````9S;&EC97-6;$QS`````4]B:F,````!
M```````%<VQI8V4````2````!W-L:6-E241L;VYG``````````=G<F]U<$E$
M;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T
M;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R``
M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``
M````````3&5F=&QO;F<``````````$)T;VUL;VYG````+`````!29VAT;&]N
M9P```-@````#=7)L5$585`````$```````!N=6QL5$585`````$```````!-
M<V=E5$585`````$```````9A;'1486=415A4`````0``````#F-E;&Q497AT
M27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG
M;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L
M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O
M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET
M;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N9P`````````,8F]T
M=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X0DE-
M!"@```````P````"/_`````````X0DE-!!0```````0````!.$))300,````
M``Q3`````0```*`````A```!X```/>````PW`!@``?_8_^T`#$%D;V)E7T--
M``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48
M$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+
M"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`S_P``1"``A`*`#`2(``A$!`Q$!_]T`!``*_\0!
M/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0``````
M```!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3
M(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T
M-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7
M9W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!
MD12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T
M9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7
MI[?'_]H`#`,!``(1`Q$`/P#U5<G_`(PNLW8&!1AXMSZ,C+?N=96XL>VJJ'V;
M;&$/K]2UU-?]3U%UBX/%_P"R+_&!;D&'X726EK9$@FLNI8-/])EV9%W]3&4N
M$#B,C\L!Q'_N6+,3PB,=)3/"/^Z+;_Q>=:ORZ<KI^9<^_(H<+JK+GE[S59HY
MFY^Y[O1N:[_MZI=BO*<%[OJM];Q4]VVC'N./82><:_::;'G_`()KL>Y__$/7
MIV>[.9AVGI]==N9$4LN<65[CINM<QKW[&?3]GTT[F(`3!C\LQQ!;R\R8$2^:
M!,2ULCK>)3UG%Z,V;,O):^QP:1%=;&EV^W_C7C94S_C/]&M%>2].KZ^_ZSVU
MXN0S]MA][;<FW5CGL&S(B:W^S:W90WT?T=?^C7;X#/KMC=/SK,^[%RLP!KL)
MI$5PT.]9MGHUX[O?^8EDPB-5(;#\58LQGQ>F6Y_YKT:%E,OLQ;F8SQ5>YCFU
M6$2&O((K>6_R'KS?IOUS^L-_VEM;W9?4^H&FKI]+6`5U#]-9DVLH'MW,8ZO^
M?M_X2^ST*5L?5W_GGC]0S<;J+GOR+,;UL5N6X/H+P_8^+L5KO3VM=[Z:_P#M
MI"6"4;LQ%=+^9,<\9UPB1OK7RH_J3T/ZS8'5K;^HMLIQS4YE_J7"WUK26.98
MT"RW=L_2/^T/V/\`TGI_Z1=-UOK+.F5-:P"S*MGTJSP`/I6V_P#!L_\`!%S/
MU.^L/6>L?6*UO4+HK9BVN&+6T,K8\6T5G3WOL>SWMWV6O1,O_*?UC=59K6^\
M4;?^"JGU&?\`7-EO_;BK?$LN3'0%>YD(A'AV%MCX?CQS!.OMPXI2XMS39Q.F
M=:ZRP965EOJHLUK!D;AV?7CL=7777^X^S](]2R?JWU+#8;\+*?:YFI8PNJLC
MOZ98_8]W\ARVNM=:P>AX/VO+W;"X5UUUB7O>?HUUM]K?HM<[W.57ZO?6KI_7
MO5KH:^C(I`<^BV)VG06UN8Y[+*]WL_D?]MJ(?#XF'$>.1ZY>*5\3(>=D)\(X
M8CICJ-<+=Z+?9D=*Q;[7^I994USGF`28YTA75E=;.1@]--^!;]G]!P+F!K7-
M<'N`?H\>WW/W^U+ZNYF5FX#[<I_J6"U[`[:&Z#;&C$Z.4"<<)LSX!+B_1DB6
M,F!RBA'BKAZAU4ES/UAZGU3`SQ7C9.VJU@>&%C';3NV.;N+=VU:?7\S/PL/[
M1B>F&@AMKG@ES0XAC7UMD-^D[\Y+[Q#];I+]3\__`*"KV)?J]1^M^7_T)TTE
MR./U/K>9C,PL)S[<D;[,J\[00'/=Z5;'NBJINS^3_P`5_A%H8'4<G`Z/?=U+
MU'Y%%SJFUV$;W$[?2K#_`,]KMW\[_HTV'-PETD(\/%QD>C3>-_O+I<M*/6)E
M?#P`^OPE3O)+F,6GZR=6I^V_;1BL=)HK8(:X#X>_T_W7V>KO_<4^E]2ZAFV.
MZ;DV^EET.+O4$`O##LMKLV>WU*GN:[V?H[ZD!S0)'HF./^;)K]9_WJCRY`/K
MB>#YP+]#_]#T+ZR=4/2>B96:T_IFLV8X\;;#Z5/];](_>[^0N!^JGUGP_J]B
M6U'"ORK\AX<^]@AI:T;*F-W?2_PEG_&6JW_C"ZWBY^=C]$IR&-KQ[!]KN)]C
M+7_H&ASO^ZE5EMMW[F]GYZ]!QJ::,>JB@!M-3&LJ:.`UHVL`_LJP*QX@)1OW
M#>_#Z8_*US>3*3&5>V*VXO5+YGRGZT=9Q.NY=>77BW8K_3-%XM`VO;.ZDL<W
M_"-WW?2_D+T'ZG]5/5.@X]UCMV12#CY!Y/J5>S>[_CJ_3O\`^NHGUJPZ<SZO
M9]-SQ6UM3K6V.,!KZOTU3W._=]2MNY<-]0/K%C8'47X>38*\?J(:6N<8:R]H
MAC7;H:WUZW>E_P`;32G&LN$\,:]LZ#YO2M%XLXXI6,H[</J3=!__`"BY'_AC
M-_BO1<C^CV_U'?D7F-^8[ZN_7C(S,NLEHONMV"`Y]&0#MMHW[66;)_SZK*EV
M.!]9Z^J8.=U0U'#Z-CUEM>1?`=:\!WKV,#7.;Z%7LJ9]/UKO4_T2&>)/!(?+
MPQ%^*>7D`)P/S<4C7@\Q_BOQZW]0R,APE]&+6ROR]5SO4/\`X`Q>D+S?_%=E
M8[,_*QG6`778]1K8="[TS9ZNW^IZK%Z-99756ZVUPKKK!<][B`UK0)<YSC]%
MK4WFK]T_1=RM>T/J^<_XOO\`Q4Y?_$9'_MQ2M`O^P?6%UEOM;5EN<\GLRTGW
M_P#;=^]9'^+_`#L0?6BPFP-^UTWMH#M-SG6UWM9_7=4Q[UV/UCZ)9ED9N(T/
MO:W;=3H/4:/HEL^WU:Y_._G*U5^+8IR,90%RQ\,P.[8^%Y(QC*,C49\4;2?6
MKZOGKW3VT56BG(HL]6A[@2PNAU;J[=ONV6,?])OT%0^J'U0R.B9%V;G75V9-
MK/1K93N+&LGU'N<^P,<^RQ[6?X/]'L0NF_6:WI[!AYM;K&U>UL^RY@'^#?7=
ML]3:K.1];G7?H.FXSWWOT:7PXC^K32Y^_P#MOK3(_$L?M\/%5[PKU\7[K)+X
M?/W.+ANMIWZ:_>=+ZR_\B9/P9_U;%7^J7_)C_P#CW_\`?4K.GY[_`*M6XMY]
M3.>UUCQ.XEY?]H%>[Z.[_!^S]'^Y^C63T/ZPXW3:+:<AKGUN>;&.9&X$@!];
MV/<S;]%5YY!'F<>2?HC+%7JZ2^;A+/#&98)PAZS')^CU'[S/ZX?\H4_\3_W]
M;/UG_P"1;_ZU?_GRM<SUC(S,W)9D7U&IV0S]4QX)?Z;'>W<P#?\`I7G=]%;W
MUAS:[.@[K&NH?D.K#*K1M?(>U[@6?R6,<HXS$OOAVXHZ7I^C)?*!'W4;U+6M
M?THLOJG4UO3'6@>ZVUY<>_M_1-'_`$%6^N3W>GB5Z["ZQQ`\6MVM_P#/CU9^
MJ5U5G2S6QP+ZK7A[>XW'U&?YS7(_U@Z;9GX0]`3D4.]2MO&[0M?5N/[[#[?^
M$4O`9\D(PU)@-O#U28N(1YLF6@XCO_S6EB,^M!Q*#C68@H-;/2!#IV;1LGV_
MNJ.'T7K#.L5]1R31JYSKO3<[4%AJ]K"S^I^>J?2/K&.G5'#RV.=742&`0VRO
M76JRJTU^UJUL'J^1U?*;]CJ=3@4G=?>^)>1]#'JV[V_2]]S]WT/T?^$3,1PY
M/;N<Y3B01C)OAG'_`+E?D&6''Z8"!!''5<49/__1]1I_FA\3^4I4?S-?]4?D
M7RRDDA^I[OHC^LW_`*IJ5W\S9_5/Y%\L))*??_KY_1\+^N[\C5T./_0<;^K5
M_P!]7R^DI9?S</.3''^=R>47ZFM^E7_7_@Y*_P#FC\ORKY9243)W?J>WZ(_K
M-_ZIJFOE5))+]*?6#^89\2E]7OZ._P"(_(OFM)5?_!7T;'_@?_"?JI8-G_BA
M;_6'Y`OG-)/YC:']^*S#O/\`N%^GO^];_P!!_P#OZM'^<'P/_?5\KI*2/Z7]
MY9+IY/U1_A#_`%?XJ2^54DY:_1?UA_I-7]7^)6UC?T>K^HW\B^6DE!B_GLOT
M9LG\UC^K_]D`.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``
M:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H
M`&\`<``@`$,`4P`V`````0`X0DE-!`8```````<`"`````$!`/_A#BEH='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_
M(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@
M>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#
M;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@
M("`@("`@(CX@/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R
M9R\Q.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO
M;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C`O(B!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE
M;G1S+S$N,2\B('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]P:&]T;W-H;W`O,2XP+R(@>&UL;G,Z>&UP34T](FAT='`Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C`O<U1Y<&4O4F5S;W5R8V5%=F5N=",B('AM<#I#<F5A
M=&]R5&]O;#TB061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RDB('AM<#I#
M<F5A=&5$871E/2(R,#$S+3`Y+3`S5#(R.C$X.C`U*S`U.C,P(B!X;7`Z36]D
M:69Y1&%T93TB,C`Q,RTP.2TP,U0R,CHQ.3HP,RLP-3HS,"(@>&UP.DUE=&%D
M871A1&%T93TB,C`Q,RTP.2TP,U0R,CHQ.3HP,RLP-3HS,"(@9&,Z9F]R;6%T
M/2)I;6%G92]J<&5G(B!P:&]T;W-H;W`Z0V]L;W)-;V1E/2(S(B!P:&]T;W-H
M;W`Z24-#4')O9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B('AM<$U-.DEN<W1A
M;F-E240](GAM<"YI:60Z,#`U-45%,3!!1C$T13,Q,3A#049"-4(V-#E$-S0T
M-S@B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z1D8U-$5%,3!!1C$T13,Q
M,3A#049"-4(V-#E$-S0T-S@B('AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#TB
M>&UP+F1I9#I&1C4T144Q,$%&,31%,S$Q.$-!1D(U0C8T.40W-#0W."(^(#QX
M;7!-33I(:7-T;W)Y/B`\<F1F.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I;VX]
M(F-R96%T960B('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z1D8U-$5%,3!!
M1C$T13,Q,3A#049"-4(V-#E$-S0T-S@B('-T179T.G=H96X](C(P,3,M,#DM
M,#-4,C(Z,3@Z,#4K,#4Z,S`B('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I(B\^(#QR9&8Z;&D@<W1%=G0Z86-T
M:6]N/2)C;VYV97)T960B('-T179T.G!A<F%M971E<G,](F9R;VT@:6UA9V4O
M<&YG('1O(&EM86=E+VIP96<B+SX@/')D9CIL:2!S=$5V=#IA8W1I;VX](G-A
M=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C`P-35%13$P048Q-$4S
M,3$X0T%&0C5"-C0Y1#<T-#<X(B!S=$5V=#IW:&5N/2(R,#$S+3`Y+3`S5#(R
M.C$Y.C`S*S`U.C,P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!0:&]T
M;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E9#TB+R(O/B`\+W)D
M9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO
M<F1F.E)$1CX@/"]X.GAM<&UE=&$^("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M/#]X<&%C:V5T(&5N9#TB=R(_/O_B#%A)0T-?4%)/1DE,10`!`0``#$A,:6YO
M`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C<W!-4T94`````$E%0R!S
M4D="```````````````!``#VU@`!`````-,M2%`@(```````````````````
M````````````````````````````````````````````$6-P<G0```%0````
M,V1E<V,```&$````;'=T<'0```'P````%&)K<'0```($````%')865H```(8
M````%&=865H```(L````%&)865H```)`````%&1M;F0```)4````<&1M9&0`
M``+$````B'9U960```-,````AG9I97<```/4````)&QU;6D```/X````%&UE
M87,```0,````)'1E8V@```0P````#')44D,```0\```(#&=44D,```0\```(
M#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT("AC*2`Q.3DX($AE=VQE
M='0M4&%C:V%R9"!#;VUP86YY``!D97-C`````````!)S4D="($E%0S8Q.38V
M+3(N,0``````````````$G-21T(@245#-C$Y-C8M,BXQ````````````````
M``````````````````````````````````````````````````!865H@````
M````\U$``0````$6S%A96B``````````````````````6%E:(````````&^B
M```X]0```Y!865H@````````8ID``+>%```8VEA96B`````````DH```#X0`
M`+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````````
M```6245#(&AT='`Z+R]W=W<N:65C+F-H````````````````````````````
M`````````````````````````````````&1E<V,`````````+DE%0R`V,3DV
M-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@``````````
M````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@
M<U)'0@````````````````````````````!D97-C`````````"Q2969E<F5N
M8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ````````````
M```L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N
M,0``````````````````````````````````=FEE=P``````$Z3^`!1?+@`0
MSQ0``^W,``03"P`#7)X````!6%E:(```````3`E6`%````!7'^=M96%S````
M``````$````````````````````````"CP````)S:6<@`````$-25"!C=7)V
M````````!``````%``H`#P`4`!D`'@`C`"@`+0`R`#<`.P!``$4`2@!/`%0`
M60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`L@"W`+P`P0#&
M`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K`3(!.`$^`44!
M3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`<D!T0'9`>$!Z0'R
M`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8`J("K`*V`L$"
MRP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#E@.B`ZX#N@/'
M`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V!,0$TP3A!/`$
M_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G!C<&2`99
M!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A!W0'A@>9!ZP'OP?2!^4'
M^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)9`EY"8\)I`FZ
M"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+@`N8"[`+
MR`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-C@VI#<,-W@WX
M#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L$`D0)A!#$&$0
M?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B8211)D$H02HQ+#$N,3`Q,C
M$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42%3055A5X%9L5O17@%@,6
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M)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0ZLCKO.RT[:SNJ.^@\)SQE
M/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C0&1`ID#G02E!:D&L0>Y"
M,$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&\$<U1WM'P$@%
M2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ3'),NDT"34I-DTW<3B5.
M;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2QU,34U]3JE/V5$)4CU3;
M52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI6;A:!UI66J9:]5M%6Y5;
MY5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@JF#\84]AHF'U8DEBG&+P
M8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-IFFGQ:DAJ
MGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z<95Q\')+
M<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S>!%X;GC,>2IYB7GG>D9Z
MI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!:X'-@C""DH+T
M@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^BF2*RHLPBY:+
M_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.339.VE""4BI3T
ME5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2GD">
MKI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZGX*A2
MJ,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6KXNP`+!UL.JQ8+'6LDNR
MPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\F[T5
MO8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=!Q[_(
M/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/N-`YT+K1/-&^TC_2P=-$
MT\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[VX#<!=R*W1#=EMX<WJ+?
M*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G'^>IZ#+HO.E&Z=#J6^KE
MZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M]OOW
MBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y!9&]B90!D0```
M``'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`__``!$(`"P`V`,!$0`"$0$#$0'_W0`$`!O_Q`&B````!@(#`0``````````
M```'"`8%!`D#"@(!``L!```&`P$!`0````````````8%!`,'`@@!"0`*"Q``
M`@$#!`$#`P(#`P,"!@EU`0(#!!$%$@8A!Q,B``@Q%$$R(Q4)44(6820S%U)Q
M@1ABD25#H;'P)C1R"AG!T34GX5,V@O&2HD14<T5&-T=C*%565QJRPM+B\F2#
M=).$9:.SP]/C*3AF\W4J.3I(24I865IG:&EJ=G=X>7J%AH>(B8J4E9:7F)F:
MI*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76U]C9VN3EYN?HZ>KT]?;W^/GZ$0`"
M`0,"!`0#!00$!`8&!6T!`@,1!"$2!3$&`"(305$',F$4<0A"@2.1%5*A8A8S
M";$DP=%#<O`7X8(T)9)3&&-$\:*R)C495#9%9"<*<X.31G3"TN+R565U5C>$
MA:.SP]/C\RD:E*2TQ-3D])6EM<75Y?4H1U=F.':&EJ:VQM;F]F=WAY>GM\?7
MY_=(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@`,
M`P$``A$#$0`_`-_CW[KW7O?NO=:*7\T'^99\D-Y?-?NK"]!?)#N#J[J+K'(1
M].[<Q'6._LIMC"9K+;*^XH]\[N=<+-%#75V0WG4UM+%4DL_VE!"`;`>\R?;7
MV[Y?@Y0VNXWW8;:YW*Y'C,98PS*K_P!F@KP&BA^TG'6#/NG[F<Q77.>[6W+_
M`#!<VVU6K>"HAD959DQ(Q`(%2]0",T`SZ;1'\IKY5U_R[^$/56_MTYB7-=G[
M.BK.I^W*ZJ;575V_=A>#'SYZM=F+RU&[L!-09AI"%UO7M8<>\<O<GEI>5N;]
MSV^"/18.1+"/+PY,@#_2FJT\J=90>U7-;\W<E[7N-Q-KW&,&&8GB9(\%C\V7
M2Q/F2>K)?8#ZD;KWOW7N@FZL[OZS[JJ.R8>LMRTV[(.INQ\QU)O3)XU7DQ-'
MV#MS&X?);EV[1Y`@09*HVZ<Y#35CPEHH:U98"QDBD"F%_M5_MBV+7]NT1N(1
M*@."8V)"L1Y!J$BO$9\^BO;=YV[=WOTVZY$HMIC%(1\(D`!90?,K6AIYXZ%G
MV7]&G7O?NO=>]^Z]U5)_.GW/\@=H_P`OSM?,?':IW7CMPKEMH4N_<UL3^(KO
M3!=05>:BA[!RNW9\.K9BBEAQYC2LJ:0"HI<9)4RJR:"ZR)[56VR77.^UP[^(
MC9D,562FAI0I\-6K@U/`'!:@SU&'O#<[_:\A;M+RZ\BWE4#M'\:Q$_J%:9&*
M!B,A2W#CUKT_\)[>POD!E?FID=N[/W5O_=/1%9UGN^N[MIJ_.Y[<^Q<7EJ..
MD7KK*3U.7JZ_&XO>M1GFDIX3`Z5U31O4B17C0LDZ>^=ER_'RM!/+#`F]B=!`
M5H'*9\1<9*`4.<`T\^L?/N^W_,LG-L]M'-.^QF!VG#:M`:GZ;9%`Y:@'G2OE
M7K=LFFAIH9:BHEB@IZ>*2:>>:18H888D+RRRRN52.*-%)9B0`!<^\17=(D>2
M5PL:@DDF@`&223@`#))X=9J*K.RHBDN30`9))X`#S)ZHX^4G\S_.U>5R6ROC
M3+1X[!T53+C:WMNOH(LK6YVJ\OVK1=?86JCEI%H&F)2+(5,4[U3E330:=,KX
M+>ZWWIKWZVYY?]L`@B5C&U\R>(SM6E+:(@@BN!(X;5Q51@]9>>W'W=[0VD&]
M^X);6RAUM%;0$6E:W$@R#3)C4C3^)N(`';>^'?SR^0,$&[=Z9[<>*I<G#YJ:
MJ[?[&W!0Y.H@<:D)V=B5R$N+@F4C1'-3TK*MOVP/8"L/9G[P7N';C=]]W6:&
M.8:E^NN&U4/`^"@9HQ\B%-/+H6W?NE[*<D3_`+NV7:XI9(NUC9P)I!'$>,Y7
MQ,^:LPKY])K??PY^:7Q]HY]ZXR?<&1Q6#1JRJS_3V_\`<=77XJ")'FGR%1MM
M'Q.:DHZ6-"\CPT]2$4%F`'/LKWWV7]\?;JUDWFPN9I+6$:FDL)W+H!Q8Q]LA
M4#)*J0!QZ,MJ]UO:'GFX3:MPM8H[B0Z46]@30Q.*"3N12:T&HJ2>'5E_\LKO
M+M+NCK[L5.SMWR[VDV9N?"XG;V:KJ.@BS#XS(X-<C-%E,A00TRY>1:DDI-)&
M)0ITLS6%LH?NP\^<U<\\L;\_-6Z&[GL[M8XY&50^ADU4<@#60?Q-W>IZQ]]_
M^3N7>4>8MH3EW;_IH;JU,CH&+('#E:H&)T@C\(-!Y`=69^\F^H$Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]#?X]^Z]T3#^81\
MF(/B-\/N[^\(ZB*/<N!VE4X3KVE>6..3(]E;NDCVSL:E@62_G,.X,G#4RH`3
M]O3R-P%)`HY*V!^9^:-GV<+6&24&0^D:]SG_`'D$#YD=`[G_`)D3E/E'>]ZU
M`7$<)6+YROVQ_L8@GY`]:,W5_P`'=Z=B?R^/D5\XUERE8>G>S]L82@B>4-%N
MW:E,\0[SWE6T[1M4U=?@<QNFAG256"C[+(%M1_3F1N/.EIMG/.Q<F:4$5Q;F
MII\#G^P44P`P4@@\*KU@YMG(E[NW(',//+%S);7*A1Y.G^CN:Y)5F4U'$:O3
MJQG_`(3O_)G_`$9_*#??QLSV0^WVM\C-L'<6U8IW5:>'MCK.BGJ7IX7ED58I
M]T=?RU895]4SX:%;$V]@3WZY=-]L5AS#"E9[)_#>G^^I#@X_A>GV!CU(?W=>
M9QMW,5_RU/)2UOH]<8)QXT0KBO\`$E<#B0,=;I_O$KK-'K7<_G3_`,UB3X]X
M;*_$KXX[C6+Y!;NPJ#LK?>'J$>?HO96;IM24V-J(BRTW:^[L?)?'J?W,/0R?
M?L%E>B+3C[2^VK<PW"<Q[Y`?W%"_Z:'_`(D.I_G$I^+R8]O#4.L>_>?W63EJ
MWEY7V"<'F"9/U74_[CQL/*G"5Q\/FJ]V"5((-_)]_FE?$SX,_%O<?3W>%=V1
M2[ORG=&]-]T<6T^O\UO#'-M_/XC:M'0S5&9I)BKY*:JP]0TZ27E!(9BQ>_L;
M^Z?MOS3S;S'#N>R6L+62VJ)F14H5+5&DTQ0BE,=`/VA]U.4N3N6;G;>8+N=;
M][IWQ&S@J0H!U5XX-1Y"E/EL>?';^8A\6?DMTON[Y`[0WVVRNJ-C[PK-C;DW
M5W%2P]6T%!GJ'%8G,2QM/NBMI:4TSTF:@\<AD'DD+*`2ON`M]Y*YBY>W6VV2
M_L2VY31AT2(^(6#$J*::YJ#CK([E[GWEGF79[K?K"_";5#(4=YJ1`,`&-2QI
M2A'GQQQZ+)A_YU'Q$[$^3G3_`,7>AYMT]V;A[4WJVT:GL+;N-?!]7[9CAP>9
MS557Q;AW%'15V[I83AS"L>,I)J=V?5]R%'J/[CVJYJL.7-QYEW>!+2U@0-X;
MFLK58*.Q:Z>/XB#_`$>@Y;^\/*&X\S[;ROLMP]Y=W#E?$0$1+05/>1WFE?A&
MG![N`(5_+?\`GV_%GXV=BYOJG8>T-Z_(W>&T,I/A=\5O7^0V]A=B[:S5'*8,
MEM^/>>?JQ3[@W!B9D:.KAQ]/44]-,IADG697C0UY8]F.:.8]OCW.:6&RM)%K
M'XNK6ZG@P102%/D6()&0*9Z)^;/??E/EG<9-JMX9K^[B8K(8BH1&'%=9/<PX
M$*"`<5K6AZ.K_P"8=\:=\_%3K?Y<[ZWQ@^ANN^R=OY7.X[&]O[CVW@=PTO\`
M`\[EMN92ABHJ;*UHSM3'DL+-X5Q_W$D\11@@9B@!NX\E;]9<R7_*]K:/=[C;
MN%;P59P:J&!K3`HPJ30`XKT.=LY\Y=O^5MNYLN[U+/;+E"R^.RJ<,R$4KW&J
MF@6I(H:=%[^)?\TWXI?)OY-5WQA^+NQMQU.'I]D[R[(S':(VI0=>['R-3MW+
M;9Q)@P.WZN&CW3GILS_>%9/OJBBHD5(?]V:A8XYF]NN9>6]AM]]YAE13),(U
MBUZY!52U6(JJC'`,?RZ(.5/<[E+F;F.XY=Y8MV94B:1I@@CC8@T[00&;C\1"
M_*O4W^:=WUD=E=?[=Z1VQ7R467[7CR%9N^II97BJZ;KS$2005F.CE0!XANO*
MSI2R,K`M1PU,?T?C`7[UWN%<\O<M[?R7M=P8[_=@QF8&C"U0@,H/EXK$(>':
M&SD]9Q_=SY)M]\W^]YIW&$/9[9I\)3D-</4J2//PU!<?TM)\NB__`,K?XW8;
M=^6S'R%WACJ?(8_9>9DVQUCC:J&.6B3<]'30RY[=QIW_`&VJ<&E5'18\E2()
MS42K:1(V2.ONH>V5ENLUY[A[S:K)#:RF&R1@"HD4?J34_B2H1*C!JP-0.AO]
MX_G^[L([7D7:[AD>>,2W;`D$HQ/APU_A:A=\Y&E3@D&]T>\^NL./LZ[]^Z]T
M6KK3I7#]"[K[\W=M#$22;:[-S.#W[3[/V[3P_>4>XZ7#U5!NFDP]%/44=(D6
M8JXHZR&%9(XQ/42JND:5]QYRSR58<C;GSMN>S6E+'<YTN?!C`&F54*RA%J!W
MGO5105)`IT,=^YKON;+'E6PW.>MW80-;B5S\49?5'K-">P'02:F@!->B_P!;
M_-"^+V,JZS'Y(]H8[)8ZMJ,;DL;7=;YFEK\=DJ2I:CK*"NI9G66FJZ.KC:.1
M&`*LI]QU/]Z#VJM+J:SN[F_BO(Y?#=&M7#*X;2585J"#@]#R#[OWN/=6\5W;
M6MG):R1AU9;F,JR$:@RD'((R.K#H)XZFG@J8M7BJ(8IX]0*MHE19$U+S8Z6Y
M'X]Y"12+-%'*GP,H(^PBO4*NC1N\;#O4D'\L'HFO;?SPZ0Z/WQD.ONQZ+L?"
M;AH(*:NB\>QZZNQN6Q=9Y5I,OA<G25$E+D<=-+!)'K4ADEB='564CW#O-_OO
MR'R)O<O+_,S7L&XJ@<?H%E=&^%T<&C*<CU!!!`(ZDWE?V@YRYQVE-ZY?CM9K
M$L5-9T5E84JKJU"IH0<\000:=&#ZS[=V5VOUG@NW-LUM12[)W!05N3HZ_<-/
M_`9J>BQU=68ZJGR,%:ZB@2.HH9#>1@-`#7L?<@\K\V;-S?RY8<U;/,QV:X1G
M1I!X9TJQ4E@?A`*GCY9Z!G,'+FZ\L[Y>\N[I"!NL#A75"'&IE#`*5J&J&'#[
M.BH=P_S(/CGUA-)A]NYFJ[<W3]S%1+BNOC3UV&IZF:IAIP,EO&HDCV]3Q#RZ
MC]O)5R\6\?/N*.;OO'^VW+%Q'MUGN)W3=6D5/#M:.BEF"]\Q_3%"<Z2Q^74B
M\M>QO/G,%N]_<6`V_;5C9]=S5&(52W;%0R$D#%55?GTIODE\Z^H?C?D8=J96
MGS&]NQ9:&GR,^R=J_:&HPE'5QI+1S[GRU?-3X_!_?Q,7IX6,E5*@#B'QLKE=
M[D^_7)OMK+#MNX"6[YA=`YMH::HU85!E9B%CK^$&K$9TTH2CY"]G^:N?X9+^
MQ$5MLJL5\>8D*[#BL:J"SD'#$`*#@M7'2X^*_P`H-O?*?9N=W9@MK9[:$NVM
MPG;>6Q6=J,=6G[PXVBRB34-=C9Y(JJE>FKE!+)$X<$:;6)/?:KW3VOW7V6^W
M?;-MN+3Z:X\)TETDZM(:JLIH10^8&?+HI]Q/;W<?;G=K3:MQOH+@SP"5'BU4
MTZBM"&`(-5/J/GTR?(CYK])?&ZK7`;KR61W%OF6DCKX]C;1IH,EFZ6CG5GI:
MW.33U-'B]OTE2JWC-5/')*GJC1UY]H?<?WMY(]LF%GO-V\^]%`PMH`&E"G@T
ME2%C!XC402,@$9Z5\C>T_-W/ZFYVFU2+:@VDW$Q*QU'$)0%I".!T*0#@D=%+
MVG_-YZ<S&8%'N;K;?NU\,951L]15>`W8M)$Y"K55^*Q-7%DHZ=6/K\"5$@47
M"M]/<2[5]\+D>[O8X-SY?W"SM&/]KV2@#^)D4AM/J5#?8>I*W'[L7.%K:R36
M&\V-U<K_`*&"Z%C_``JS+IKZ!BH^8Z.GN_Y0;-PE-LC+;6I?[_;;WM@QN>@W
M'@LI21XM\`96A%3132QNM55JT4@DBE-,D,JI#)(D\L<9F+F7W9V?9+?9+[;K
M<[AMEY$)A+$XT^$Q*@I4'6U0=2G3HH`Q#,!U%FR^W>Z;G+NUI?3"ROK20QM'
M(K:O$`KI8#*CA0@,6!+*"JL1_]'?X]^Z]UJ-_P#"D#Y)5VYM^=&?#794LF4G
MP"4_;^^,)0S>4Y3>^ZYJO9/36UJJE1-8K=$^2K$7GU5E*U@;'WDW[![#';VV
M]<W7H"Q@&&-CY*HUS,/V*M?DPZQ,^\;S%+=7FP\F63%GJ)I`*Y=SHA4CSI5F
M^Q@>M@WXM_#_`&=TO\&^O_B#N3'4^5PHZ@K-E]GQ::<C<>>W[C*Z?LZKFF2-
MDG;*9W/5QCD;4PC*"Y"CW!W,7,UUNW-U]S/%(5E-UXD9_A5"/#'RHJK4>M>L
M@.6.4K/9^2;#E*>(&'Z0QRB@[FD4^*3Z]S&A/D!Z=?/_`-Q8GLKX*_*W(XJC
MDE7M#XD=Y1S8>I8$#.-U_G8<E@*H^0#S4&_=F/`7)&F2GR+"UC;WF_;26//'
M*<<C@&RW*SH1_"SK1OL*2`_/MZP#N8MPY#YREC4E;[;+VH/J$:H.*U#I3]O7
MTD.H.T-K=U]5]==O[)JTKMI=F[+VWOC;]0DL<Q_AFY<32Y6F@F>$L@JJ5:GQ
M3+]4E1E(!!'O`3<]ON-JW&^VVZ6EQ!*T;>65)%:'R-*CY==']IW*VWG:[#=K
M-P;:XB61:&N&`-/M'`_,=:KO\_3X>_&KX\=;]2]G]-]4879/8G;'?VYG['WG
M2Y+<>5W!O%LKM+<NY<DV;K\_F<L]7)69R-*AG-G#(JJ0@T^\C_8_F??=XW'<
M-LW+<6EV^WLU\.,A0J495&D*H\L=8M_>`Y4Y>V3:]JW3:]L6+<;B\?Q)-3LS
M@J7()9FP6)./,GUZ5_\`)$^`WP[^4_Q&W9V'\@NA=G=H;WQO?6_-I46X]P39
MZ.N@VWB<%LRKQN(1<9F*"F%-1U.3J'4^/63*;DV%D_O#SIS5R[S1!8[+O<MO
M9FT1]":::BSU.5)J:#]G2CV1Y#Y0YGY2N+[?MAAN;U;MU#OJKI`6BX8"@J?+
MSSY4V$>O?A!\2^K.I=V=$;&Z&V#B.G]]9;(YW=O7M3CI\]MW-YG+8JDPE?E*
MJEW%599DK9<70PPB2-D:,1@II;GW!5_S5S%N>Y6V\7V[S/ND(`22M&4*2P`*
M@>9)_//60VW\F\L;5M5WL=ALT,>TSDF2*A96)4*2=1;R``IPH*4Z^=%M+=>]
MNC>Z:C-=-5N5HM^[&W]O_8W6==0@5>X8*[)Y+<O5N&CQ32$^3<=5B\O]M2S$
MZDJY5E!U*#[STN8+'>M@0;VJM8R01RRAL*=`60EOE45(_+KG1:W%]LN_RG9'
M9;Y)Y8HBOQ#4S1C3_2H:`C(X];6'Q\_X3B_'NBZ-PE'\BM[]GY#O3,8*&JS>
M2Z[W?3X#:77V7JZ9)Q@MM8N7%Y.#="X.I<QU-?E&J3E)5>0)"KA!C1O7OUS`
MV[2ML5M;Q[,C419$U,ZC%6-1IU#@%II&*FG65NQ?=UY<&R1#F*ZN9-^D34[Q
MN%2-SFB+0AM).2U=1]!T.'='\OC9W5_\FK?GQ_[>Q^S>P=[?&GJ/NG<'7';$
M.WJ2/.XVMVYN_>O8^Q-SX*JJ8Y\KM?(UN-J*6/)T=/4&$M)40:I86NQ%L_.]
MYN/NK9[_`+<TD$-]=PB2+5VD.J1R*P&&%=14D5X'!Z/][Y"LML]GK_E[<XHI
M[C;[2=HI=/<"KR2QLI-64T(#"N<@UZI2_P"$\3^3^8'626MY/C;V6]K_`$U[
MJZR;_8VO[F'W]QRA8^GUZ_\`''ZA#[N9KSO<D\?H'_X\O5G_`/,TS-5D_EON
M"AGD>2#;>PMB8JAC=B4@CJZ7(YVH\2\A!-492[?U(]\`_O57DMQ[MW=NS$Q0
M;?;JH]-09VI]I;/V==W/NZ6T4'MM#.J@2S7T[,1Q.G2@%?D!C[>K@/Y>..I,
M=\/.FGI8UC;*8W<&9K6`4&:NR.[<]-42L1:['A03SI4#WF=]W:UAM?9SDLPK
M0RPO(WS9I7J?MQUBS[W3S3^Z/-OC.3X<RHM<T58DH!\AUKN?SU_YA/R0VM\E
MY?B?T_V+NWISK_8>P]H;FWEDMA96?;F[.P]Q[[IZ_(T]/5;JQ_ASF,VI@,+#
M%$E+13P?=5DLSSNZQPHG0WV8Y#V&^V(\R[M8QW5U+,Z1K(-21JF"=!P68GBP
M-!2GG7GE[[>X7,5COXY6VB^DM+.*%'=HR5>1G&H=XH0JB@H#DU)KBBL_D,?S
M`_D5V!WMG_BAW1V!NGN#9^9Z[W!O[8.XM\9&;<&\=C9;9M;@:/*8-]T5IDR^
M7VGF\5F4:*&MEJ)**KIAXG5)W3VF]ZN1=BVW:;?F79[-+6<3K'(B#2CA@Q#!
M1A6!%#I`J#G(Z4>PWN%S!N>\W'*F\WDEU;&!Y8WD.IT*%:@L>YE(;%3@C'G7
M;+]XT=97]:J?SKH:3'?+;O*&CA6"*HW/@<C*B<*U;D=M;=J:V>PL`U14,7;^
MK,3]2??)KW\@BM_>?FY(8PJ-=6[FGFSK&S'[234]='O9:62;VNY8:5RS+#,H
MKY*KR!1]@&!UM-8?_BT8O_M6T/\`[BQ>^K.W_P"X%E_S13_CHZYTW7^Y5S_S
M4;_">J+/YNT$"]G]+50B05,FQ-V4\DX%I'@AS^+DBB8_E(Y)W91^"Y_K[P-^
M^0BCF'DB0*/$-G."?,@2*0/L!)/Y]9A_==9OW-S>FKL%S":?,H]3^=!^SJQ#
MX`TE+7_##I>CKJ:GK*2IP&?BJ*6KACJ*:>)MX[C#1S03*\4L;?D,"#[R/^[Q
M''+[+<E12HK1M;R`@@$$>-)@@X(Z@KWK9D]U.;71B'$Z4(P1^C'P/5#WS!VK
M@>N/E/V[@]K8^AQ."QFZL5N'&XFEI8:;%8R;*X?#;BJ:2EH8@E/!CERL\LBP
MHJQJKE%`4`#`#WGVRQY9]VN:[?:($AM8KN.9$4`(C%4E("\`NNIH,9IPZS0]
MJ;^[W_VTY;EW.9Y;A[=X79B2SJ&>,$MQ)T46O'%>/5@GQF_E^XGO79\O?7R4
MSV\<CNCMRHJ=Y8["XK+/@ZFGQN9=IJ'/[@KQ3RUU9E<O2&.:GIE9*6BHO#%I
M<@A<C?;#[N]ASULK<^>YU[>3;ONI,ZQK(8RJ-\+R-0LSN,JN%1-/$G$&<_>]
M]WRANB\F>WMI:P[3M@\%G9`^IE^)4%0%134,V6=M1-/,Q.#V'3_RY^A_DAN;
M&9K^]N"FS=/N;K.++F)<TV8S.&Q&U\/MS/\`@AIJ6N>DW$L;&>%4,]&;LJ.K
M7DRRY?MONX<@^XVYV=ZUSMYE\:T$E/$UO&L:1.<!],F:@#4H.`>@#>;W=>^G
M.?(]A=VPM[_PO!N62NC0CO(TB#)6L=10U`>E"0>B$?R^OC]0_);M7?\`VYW3
MY-]8K:.1I<AE:?.-)54^]NR=R&;)&JSJ276OQ6!H85F6C)\!>>G1E,,7C;'S
M[NO($?NAS7S!SSSM6^M[:4,PD[A/=2U:L@/Q)$N0GPU*@B@H9L]\.<Y/;_ES
M8^3^46^CEN(B`T?:T5M'1:(1\+R-4%_BPQ!J:BSSYD_%WKKLSHG><V%V?MS`
M[WV+MS)[HV/F\)AJ'%5E+5[?HI,C)A)'QU/`]3A\U1TKTLE,^J,&174!T5AE
M)[S^UG+/,_(.]FUV:W@W>RMGGMY(HTC96B4N4J@&I74%=)Q4@\1UCU[6>X6_
M<N<Y;29MTGEVRZG2*>.1V=661@NJC$T9"0P89Q2M">J_?Y4G8M#EMQ;NZ4W-
M1X[,X5\8.U>O(<Q34]><#FDJZ*@W=2X9*F*44D>32JHJYE0JHJ(990-3$^\=
M_ND<S1WEYO/(F[PQSVZQ_66HD4/X3ZE6=4U`Z==4<@4RI/GU-OWE^7FM;?:N
M;]ND>.=I/I;DH2OB+I9H6>E*E1K2IJ2K`<!U_]+?BSV<Q&V,'FMR[@KZ?%8'
M;V*R.<S>4JW\=+C<1B:.;(9*OJ9.?'3T='3O(Y_"J3[<AADN)8H(4+32,%4#
MB230`?::#IJ>>*V@FN9W"PQH68G@%4$D_D!7KYR>X/EIO?M#YZ9[YRT7659W
M!F(NYO\`2YM+KW(8C=FX<+3[;VRS8?I[&;B3:5!796CQ>V\-C,;4Q(0D<E?3
M$&X+CWG?!RQ8[9R+;\G3;HMFKVOA/+J0$N_=,5UE02Q)'J!USMGYIO\`=O<&
MYYVAVEKUTN_&2(JY4(ATQ!M(8@*`OR)ZMV_Z"%_GI_WA)LW_`-`WY$?_`%I]
MQ9_K'\F?]-Q_QJW_`.@NIB_U_>>_^F#3_>;C_-U3A\VOD5V-\N>[JKY$=F=%
MKTENG<6W-N[4W!'A]N]AXO;>ZLAM>*L@Q.:EK-]XZEMN/^!/'1O#!(1)2T,3
M:;HS>Y=Y)V3;N5]H_<.W;Z+V))&D6K1ED#4J-*,>VN:GS)ZA/GW?MTYJWD\Q
M;IL'T,TB*C45PCE!0&K@=U*"F<`=;-G_``G0^30WY\<M_P#Q=S^1$NY?CON@
MYG9U//.IFJ.I.RZS(9G&14D!`D^VVQO2'+4;6)6*&:F7@%;X\>_'+HV_F*TW
M^".EM?Q]Y`P)HP`U?FRZ3^WK)O[N_,YW+EJ\Y<GDK<[?)V5K4PR$D4^2O4<?
MQ#I-?\*7?^R??C%_XGO+?^^UW/[4_=]_Y6#?/^>,?]7!TC^\K_RKO+W_`#VM
M_P!6ST+'_"<3_LA/??\`XLYV9_[S77WLM]^O^5RM?^>*/_CS]&GW<_\`E1[O
M_GND_P".KU?Y[A+J?NOG'_#'#X_<'\T#X^8?*T\=7CJKYP5U344LR+)#-)A.
MPMW;AHEEC<%)(UR.(A8@\$#WGCS7-)![9[M+$U'_`'4!7Y-&`?Y'KG7R9;1W
M7NILT,RUC_>Y:GKIE8C_``=?1P]X'==%.B??S!_^R%_E[_XKGV]_[P^9]B?D
MK_E;^6?^>Z'_`*N+T$>?O^5)YK_Z5\__`%;;K4I_X3N_]E_U'_BM/9'_`+U'
M6/O)KW]_Y5"R_P">\?\`''ZQ-^[G_P`KO<_\\#?\>7JVW^:?LRLV_P#)+$[O
M:-_X;V%UWB'I:@1D1')[/K:O$9.E,I]+SQT-=126^H1Q_C;@W][78Y;'W'L-
M[=:VU_MZ`'RU0$HP^VC(:>G7<G[M>[Q7?(]_M(/^,6=ZQ(]4F4,I^S4K"O1\
M?Y5_:%#NKH"MZUFJD.X>I]S92C>A8A9/[K[IK:O<6WLA$I;4].U34UE*2!99
M*4C\@>\@/NH<UP;Q[=ORZTP_>6U7#H5/'P9"7B8>9&64G@"..>H7^\7RY-M7
M/'[\2&ECN4*N&\C+&`DH/H<*U/1ND3_,<_E&=2?S`<WMOL@;YSG3/=.V,(-K
M#?."PN.W)B-V;4@J:S(X_`;TVQ75&..0;#Y*ME>AKJ>LIJJFCJ)HV,T;(D>=
M_(?N=NW(\=Q9QVJ76URMJ,3L5*O0#4C"M*@=P((-!P-:X3^XGM-L_/\`)!?/
M=/:;Q&ND2JH8,@J0KJ:5H3AJU`/`XH[_`,N'^5#U)_+WEW9O*CWCFNW>YM[X
MRGV]ENQ<_B:';U+@]IP5,61;:FSMLX^HK8L1CZ[*PI45M1/4U576/!"&=(XE
MC]L\^^Y6Z\\M:V\UNEMM<)U+$A+5>E-;L:%C3`P`*GUKT][=>U>S^WRW-Q#<
MO=;O,H5IG4+1..A%%=()%6-220.'#JUCW'/4H]:K_P`^/^RNN[/^UUM3_P!Y
M3;GOE!]X/_I]/-?_`#7M?^.1]=&O9+_IUO+7_-.X_P"KDG6T=A_^+1BO^U;0
M_P#N+%[ZI[?_`+@6/_-%/^.CKG9=_P"Y5S_S4;_">J,?YN__`#,CI+_PRMX_
M^[S"^\$/OD_\EWD?_GDG_P"KB=9A?==_Y)'.'_/1!_QU^K$_Y>W_`&1STC_V
MI,]_[V.X_>1_W=/^G,\D?\T)/^KTG4%^]W_3TN;_`/FNG_5F/JC+^8'&LWRX
M[K@;]$]5M.G?_@D^SL!$XXYY1S[P.^\#&)O>CFF!OADF@4_8T<:G_#UF%[*2
M&'VLY?F'%(IV'VJ\A'^#K9]VQCZ?$;:V[BJ1$BI<9@L1CZ:-!9(Z:BH*>FA1
M!Q94CB`'^'OJ7L\"6NT;7;1C]..VB4>E%10/Y#KGG?SM=7U[=/77)*[&OJS$
MFO[>J\/YK,M1'\7:1(B1#/VQL**LLQ6\`.6FB5@`0ZM6PQ"QL/S^/>.OWM'E
M3VHHGP-NEJ&^RKT'YFG4Y?=M$9]R`6IK&WW!6OK11_QTGJL7X<_&_L7Y"XK?
MQZ][XR_4C[1S&%ARV$QL^Z(5S*YC'S3469E&W]R8&%RGV,M.#(DK_M6U`6'O
M%KV1]M>9?<&PWYN7?<&?:&MID$D4;RKXFM3ID(C=1BA6I!^WK(/W9Y\V'DN^
MV9-\Y(@W1;B%RDDBQG1I:A0%T;U#$`CB,'HYDO\`+7^1<\4L%1\Q]RU-//')
M!/3U%1V+/!/#*ACEAGAEW\\4T,L;%61@58$@@@^YND^[3[DRQO%+[RWC1,"&
M4R7)#`X((,E"",$'!&.HF3WWY#C=9(_:>S5U-00D`((R""(L$'(/ET(OQ;_E
MV[K^/'=6W>U:[M7`;DQ^&P>YL+48''[3K\5/51Y_'QTL+1UDV;JX84I*B".0
MJ8CJ"V%OK[$GM1]W/=/;7G2UYJFYJAN8$AEC:-8F4L)%('<3^$T;YTZ(_<CW
MQL.?.5KCEU.7)()6FCD60R!@I0YQ0<5JOY]?_]/8V_GU_*RFZ)^&63Z<P&8%
M)V;\I*N;K7$TM+4O#DZ'K:F%-7=L[C'B.J*C_N])'AM;6!GS48%R#:7?9CEE
MM\YN@W":(G;]O'BL?+Q.$2_;J[Q_I#U"?OMS8G+_`";/M<$P&Y[D?"4`]PCP
M96X\--$/^G^708?\)T_CY#U]\2MZ=^Y"C6+<'R*[!K3BIFBCO'UOU9-D-G;8
M@IY-/D6GK-QG-UA6^DBH3BXX,O?C?6W#FN#9T/Z%A"`1_P`,EH[G]F@#\^BG
M[NW+Z;=RA<[XZ#ZC<)R1_P`THJH@_,ZR?R/6PC[A#K(+JN3^;!\:O]FE^"7>
M&Q,=2Q5.]-I8+_2YULT@8O'OKK%)MRX^E@T*S"3<&*IZW$GC_-Y!@>/8Y]M^
M8/ZM\Y;-?.U+9W\*7YQR]I_82&_VO4>>Z?+8YIY'WO;T6MU&GC1?\U(JL/7B
MNI?SZTN_Y6?RUHOB/\S>G^W,WEFQ/5N]4?JOMNIFF>&AI-@=A24"T.Y,JJ+(
M6I-D[NI<9E)FTDQ4L-01:Y]Y;^YW+#<T<I;C801Z[^#]:$#)+H#J4?Z=-0^V
MG6&'M1S6O*7.>VW]S)HVZ?\`0FJ<!'(HQS^!J-Y\.MB#_A2AA<AD/BW\>=TT
M<7W&#P7R$IZ;)5T(\L%.VYNO=W4F%D:5+HL-954_B1OHTDB*.6'N"/N_SQQ\
MS[O;2&DSV9H/70ZEOV#K(7[R-O)-RKL=W$NJ".]R1D=Z'3^1H>BW_P`AOY]?
M&3X_]$]L]$=^=K;1Z>SE+VGE^T-J9/?>17!83=NW-S;;P%'E8L;FJI5QS9C;
MF4VW(LU&\B5#P5$,D2R`R>,0>]?)7,.\;YMV\;+MDMU`UN(W$8U,CJS$549H
MP84-*5!!S2H;]A>?.6=CV'<]DWS=8;2X%R94,K:5=&4`T8XJI!J.-"#G--@?
MXI?-'KCYG9/MO-]%T^0W#TOU?N/&;`QW;]52U6-P?9._?X:N;W=2;&HJZ"GK
MZS;.S<?D,=#+D9DB6LKJJ1($,5/YIH+YAY7W#E?Z"#>%$>YSH9##4%HTK1?$
MIP9B&.GR`SDT&0W+7-NW\VON4^RUDVFW<1B:A"RR4J^@$5**"O<::B:@::$Z
M,GP9JZ1?YI7QQK#4PFDF^:^8\-4'#02_Q+=V^:7'F.0>EUK:BKB2(C]1D6WU
M]YD\Y))_K8[NNDZQM:U'F*(M?Y=8,\B21CW6V-]8T'=B`?(UD8"GV]?1C]X(
M]=$>B:_S$:RDH/@?\P*JMJ(J6FC^.G;8>:5M**TNS,M#$I/)+232*J@<EF`'
ML4<CHS\X<L*BDL;Z'_JXO0.]PG6/D;FQW("C;YO^.'K4N_X3R3P4O\P7[>HF
MCAGJ_C?V;34L+L`\\\.XNMJF:*(7];QT\#N;?V5)]Y.>_<;OR;;.JDHE\I)]
M`5<#]IZQ-^[I(B\]3(QHS6#T^=&4FGY9ZVWOFC\9X?DSU+-@,7)24'86TZI]
MR]=9:L/CI5S24[T];@<E,%9XL/N:@)IIF'^9E\4]F,(4\VO>OVPA]T.4)=L@
M98]_M6,UI(W`2`4,;'R24=K'R.EO+KI?[5>X$OM]S/%N,JL^SSKX5R@XF,FH
M=1_'&>Y?7*_BZUVNK>SNU?BGW$^>Q>.J]M;YVI--M[?&P]S1STD.8Q$LT<M;
MMO/P179J*HDA2HH*^'R*DBI40&1"ROS=Y4YJYO\`9OG9[N*T>WWBV)BN;64%
M1+'7NC<>8-`T<BU`-&4]9U\R<N\L^Z/*:VS7*S;7./$M[F.A,4E*!U]#^&2,
MT)%5-#0B^+K+^95\8-\8BGGW3NJ;J?<`CC%?M_?5'5PP0U#*/*N/W)04U5@L
MI2(YLL@EB=ART:&X'0'E?[S'M9O]G'+N.\?NJ_TC7%<@KI/F%D4%'']($?,`
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MP$(=F=$)_M)`*&23Y@8%!T=^\W)W*G(&R<K<M;/.LN^:Y);EVIXS@JJHS`5\
M-"0WAQ^E6R22:T?YC&V<C@_EMV>95D@7=.)V=NK"54T9$512U&W:7$-/$;`2
M14>9PD\3VO8Q\_4>\6?O*[9=;;[Q;_/*M([F*WGB)X,`BJ:?8ZE?M'61/L'?
MVU_[8[-#&P+V\L\,@'%27+BOS*.#3Y]7)=5_/OXU9SJC;NY=V=H;>V=N"@V_
MC*?=NU,]+-3[CQN?IJ..#(4M)B8H9JO,TU15PNU)-1K,E1$R$68E%S5Y3^\!
M[97W*>V;ENG--M:7Z6R">"4D2I(J@,H2E7!8$H5!U`CSJ!BAS#[,<_V7,=_M
MMCR[<75JTS&*:-:QO&S$JQ?X4-"-88C2:@XH32=\Q_D1/\F^TXM]XS#9/#]=
MX"AJ]F]>')TLE/4Y2EH*Q:W<&8K+EJ=,G75]3%Y*9&9Z*G2!);2LP]X,^]_N
M2_N?S3%O=I:2Q<LP(T%F7%#(%:LLA\M3,1V5)1=()K7K+SVEY#7V^Y=FVJZN
M8Y.8)W6:Z",&$=5I%'CR50>XX9BQ&*=7-?RV.Q-I;B^,&P]F8_-XQMU;$?<>
M"S^WC7TPS5(R[CR>4I*^3&&05BX_(8_)PR13:#$UR`VI6`S9^[+S#M.Y>U6P
M;3:WT3;G8^)%+%J'B*?$9PQ2NK2RL"&I0Y`-0>L3O?O9-SV_W&WS<;FT<6%X
M8Y(I*'0P,:J0&X:@5(*UJ,5%".J9OGU44\ORY[LFCF1XZ;+[5@J'4C3%-2[1
MVZU1&Y-@&A4C5^![PI]^IHA[U\T2^(-,=U;U^6E(BP_(9ZRM]F8I#[4;#'I.
MIX)]/SJ\@%/SZVB\+/%4X;$U,+B2&HQE!/$ZD%7BEI8I(W!!((96!N#;WU0V
MR19=NV^5#V-!&1]A4$=<[[J-H;FXB<=ZNP/V@D'H!/EGTU4=]=!;_P"NL:8%
MW'6X^#,;1EJ"JPINO;U5#F,)%+(S(D4-=54GVTCDV2.=B?I[`GNWR4W/_(',
M'+<%/KWBUP$\!-&=4?R[B--3@:J^70Q]N.:AR9SGLF_RU-I'+IE`XF)P4?UK
M0'4!YE0.M=CXN?(7<GQ4[?GW)6X')SXN=:C97:>QIT%'G$IJ&N+3)#!5F..G
MW3M/*([Q1R%%F1I82ZB57'-OVH]QMS]H.<[BZO+"0VC5M[ZWX2`*W$`_Z)$P
M)4&FH$BM&ZSM]R.1MO\`<[E:&WM+N,7*_KVDX-4)9>!(_P!#E6@)%2I"FG;3
MJ_K#?/'XD9G!Q9U>[]GXJ)H(YJC&9^>JPV?H7=`QI:O!UM-'D5JXR=)5$<,P
M])86)Z&V/OU[17UBE^O/-G$A4$I*Q21?DT;#4&^0!^5>L)+OV>]R[2[:S/*%
MW(P:@:-=<;?-74E2/G4?.G21ZI^6J?);NN3:'1V.R$O477-#/F>S^S\QC*C'
MQ[@RU='+2;1V/L^AK8!4PQ5\WDR-95U*03-2T@CB0+-Y"7<H^[D/N7SA)M/)
M%I(_*FWH7N[V1"JR2,"L-O`K9R:R.Y`)5:*`#4KN9O;6?D+EB'<^;9T3F*^8
M+;6BL&:.-:&2>8@T%,1H@)[F))[:=?_4L?\`YEW_``V?_LV&Y_\`9]?^'(O]
M,_\`!*/^[7\'_NU_HU_T9_?5?\)_T-_P/_<1_</^,?<^;3_EO\3\WWW^4>\D
MO;G_`%Q?ZNI_4G]R_NW6=>K^U\2G^C:LZZ4IY:=-,4ZQ9]S/];3^L3_U_P#W
M[^\]/Z>G3X7AX_L-.?#KZXUZ_P`6KJX3^45_H0_V6&D_V5K_`&9C_9:O[Q[F
M_P!&_P#LR?\`=S[_`.]_C=7_`'M_T>_8?[^+^Y/]Y/NK?=_Y-_$/N?MO3J]Q
M;[E?OO\`K-<?UE^C_?\`I7Q?IZT^$:==<:]-*T_#IZEOVK_<7]5X/ZK?6_U=
MUGP?J=.JM>[1ISHKZ_CU^=>K5?<?]27T`GR?_P"9!=K>;_2A_"O[D[B_O)_H
M5_N__I6_NM_"JO\`O'_<+^\O^X[^\O\`"?+]KH_ROR6^W_?\?LTV75^]MOT>
M#XOBKI\6OA:M0T^)3.BM*^5...B3F'1^Y=SU^/X/@OK\&GBZ*'7X=<:]-:>?
MIGK2=B_Z!ZOX9%X_^'&_X3]@NC7_``W[3^&_;C_.^;T_;?:_JU\:;W_/O+H?
MZ_&H_P#)%U5^76&+?\#WJDU?OW54UI2E?.FGMI7TQZ8IUL3X#_9-O^&HMS_[
M,3_LR7^R/_W)QW]T?]FV^Q_TV?W-\E!_HT_T?_W>_P!_M]Q_$_X?_<K[S_<O
M?[?1_DWC]P"?ZT_ZXL'[C^C_`*U^-GZ3^QUY\357MX:O&\OB_%7K(S_D)?ZV
MUU_6+ZO^I_A]OUNGQM&/#\/3Y5IX']'33LZTWZ7_`&2W_2E'_%?]G,_T#?WF
M77XO]`G^E;^ZGW@T>3_ET?Q+['_CG_E6OZ?N>\NG_KI^Z3X7[K_?NC_AWA:_
M^+X?A_+K"U/ZA?O8^+^]/W#K_P"%>+I_STXTS_+K>CZ6_P!EA_X;<QO^R2_Z
M1O\`9=_]&FX/X+_H`_AW^G;[6^0_TA?PW^^_^6_Z:_XG][]]]Y_N6_BNOP_O
M^'WA=O/]8?Z\2?UJ\+]^_4KJ^HKX-<:-6G'@TI2F-''SZSKV3^K'^M]'_5#Q
M?ZN_3-3Z:GCTH?$I7_1ZZJUSJX?AZU?-D?\`#$/]Y]C?Z-O^'0/[]_WJVI_H
MW_NM]I_>K^_7\;H/[F?W=_W?_>/^\7V_VVOG[BVO^U[R(O?]>GZ"\^O_`''^
M[?!;Q-5-/A:>[5YZ=/'Y<>L:+#_6(_>MO^[_`-_?O;Q_T].FOBZC\'X=6KX=
M/XJ:,TZWD=G_`,4_NK@/XY_&/XM_":+^(?WA_@G\>^Y\"^3^,_W:_P!^_P#Q
M3_CO]E_DWEOX_3;WB%/H\631314TI6GY5S3TKGUZS4M?$\"'Q-7B:1752M?G
M3%?6F*]5Y?S8/]#_`/LI>Z/]F/\`]F/_`-ET_B6'_P!+W^RT_P``_O+_``;^
M*T'\+_OG_$O]S7^CW^,>+^(?P_\`/C^Z_P`F\GL;>W?[U_K/9?N'Z+]]Y\'Z
MFNC50UT^7B4KIK^6>@)[F?NG^J]W_6#ZW]P57Q_I::]-1377/AZJ:J8X5ZH)
M^$/_``TG_LUW2_\`LG7_``Y1_LQO]X:S^X6K^[/\'^T_A57_`'J_OK_'?]PO
M^CS^[WF_C/W7[7VOZ?WO%[FGG?\`UT_ZL;G_`%L_<O[CH-=/BU5[/#TY\35\
M%//J!^0_]:/^M.V?U+_?O[_U'173IT_CUZO]#I_:?T:^5>MR1;Z!JOJT\_2^
MJWJ_3Z;_`.M[Q</GUER.!_GT0/YM_P"R2_PJA_V9O^$_WM^QE_NQ_=G[_P#T
MN?::AK_@_P#=K_<W_#->JWWO^X[5J_M7]X_^]_\`K(_10_ZZ'@?O'2?!\*OU
MU,?V?A?J:?37^GQIFO4S>TO^NS]9)_K>>/\`1ZAXNNGTE?\`AGB?IU_TO?P\
MNJ"M\?[+Q_%ZK_1O_LP7\$U_Y)_>W_1GY/'Y.=7@_P`MOX_TZ_S:_P"??._F
M'_6N^KE_JU^_?HZG3XOT]*?GWU^WK-K8_P#7%^EB_K!^YOJJ=W@^/753_>*?
MZ7H8^@O]D4_CE'_IW_T[>+[V+Q?QW^"?W!\>L:O[P?Z./]_)_#[?YS5^UHOK
MX]COVX_X'[ZZW_KQ^]_C%/&T?3UK_HGTW?X?K7\^@?SU_KV?1S?U2_=?AZ37
MP=7U/^T^H[=?^ESZ=;+?77]P?[C[8_T6_P!V?]'O\*A_NG_<[[#^[7\*]?C_
M`(5_#?\`(_#Y=6K1ZO)JU>K5[Z><O?N+]R[;_5CZ?]P>$/`\#3X6CRT:.VE>
M/GJK7->L`]Y_>_[UO_W_`./^^-9\7QM7BZO/5J[JTIQ\J4Q3JO/^9=_LKW]U
M-J?Z9?[S_P"E#1E?]&G^C;^'_P!_?L+1?Q;^(_Q7_<'_`')^\\'F_B/[?W.G
M[;]W7[QR^\Y_K4_N;;/Z\^/_`%D[OHOI:?54_%JKV>!7CXO;J^'.KJ</8+_7
M&_>]]_4_P/W)V_5?4U^FK^'X>_QJ5T^'W:?BQ3JFGJG_`&57^]]%_IH_T]_W
M1\B_\6;^YOCT:TT_QW^[G^_F^TM_P(_AOKT7T<^\)^3O]9[]]0_UX_?7[IU>
M7@TIY>+X7ZNFOQ:/PUZRPYI_UT_W3)_5+]T_O'2:U\757S\+Q?TZ_P`/B>=.
MK%/EC_LFGWWQ-^__`+V?[+K_`'*W]_=+_07_``K^!>/^+;5\W\5U_P"_CU?=
MW^_^S_W)^?7]Q^[?WDS[O_ZR7U/M1^\/J/Z@?27/@?N[3X5-47QT_4I7X]/Z
ME:Z^[J`?;+_79\+W)^@^G_KI]3;^/]=J\6M)/AK^G6E-&OLI31BG5@_QG_V4
M3^[%7_LJ_P#HW^Y_ALWWG]VOL?[_`'Z?1_>/^/\`^_MU?=6M_$?V?+?_`!]Y
M$^V7^M+^ZF_UK?W;31GP=/U%:#^UU_JUKQU]M>H2Y_\`]<K]XK_KA_7^+JQX
MVKPO^;>G]+A_!FG51G8__#=W]^M__P"E'_9P/[_?WGS_`/I`_C7\.^\_O#]U
M+_%_O/MO\B\/_'+P_P"3_;:/%^WI]X?\U_\``U_UBW[^M_\`6O\`K)]3)]5K
M^+Q:]U:>7\-,::4ZR<Y:_P!?G]Q;'_5K^KG[D^GC^GT4IX=.WCFO\5<ZJUSU
M>!\</X?_`*&-A?P3_2/_`'9_@%#_`'2_TL_P_P#OY_=;[>+^"?QO^'^K_@#H
M\'W/^5_;Z/+ZK^\Z?;[Z?^I^P_0_7?NWZ=/`^LI]3X-/T_%IYZ:::YTTKUB#
MSEX_]9]Z^K^D^N\=O%^EK]/XM>_PZ^6JM:=M:TQT.!]C/H,'JES^8=_LD/\`
M>JL_O7_>W_9@?LZ;^)?Z&/X=_%_%X(_X9_I'_C'^_/\`+]G_`,!_N/\`<IX=
M%OV='O"G[QG^L5^\)?WY]1_7S1W?0:?$\M/U6K]*M/AU_J4XXIUE9[&?Z\'T
M2?N7P/ZFZC3Z[5X5<ZOI]/ZO'XM'97^E7JJ;9W^R]_WDH_\`2%_I_P#[K?<#
M[G^[7^C/^+_:>G5Y;_N^:^K_`("\VM;GWB%L?^MA^](OZR?OS]SZ\^']-KT^
M>JG=6G\'63&\?ZX?[OD_</[G_>>G_1/J-&K^C7MI_I\=;-7Q/_V7O_0U@?\`
M9:/X7_HZ\U5Y?M/NOXU_>/\`:_C/]\_XG_N<_O=Y-'W/WO[VG1H_9\7OJ5[4
M?ZWO]3=O_P!;3P?ZN?T*Z_$H-?CZN_QN&O7GA3MT]<]?<7^NO]:K[^OWC?O_
5`!7733HSH\'3V>%_!H[>/XJ]?__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
